# BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 ...

- URL: https://theranews.net/blog/2026-03-10-bpl-003-phase-3-program-initiation-on-track-for-q2-2026-following-successful-fda-e6e77c/
- Published: 2026-03-10
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: hastingstribune
- Original report: https://www.hastingstribune.com/ap/business/bpl-003-phase-3-program-initiation-on-track-for-q2-2026-following-successful-fda-end/article_c13544ca-eee6-5d94-a3eb-7b32b01acd28.html
- Topics: depression
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> BPL‐003 holds Breakthrough Therapy Designation and is supported by positive Phase 2b results in treatment-resistant depressionCash runway reaffirmed through the planned early-2029 topline readouts from both parallel Phase 3 pivotal studiesCommercial readiness advancing with scalable treatment model

---
![BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 ...](/uploads/news-images/bpl-003-phase-3-program-initiation-on-track-for-q2-20260310230039.jpg)

---
*Originally reported by hastingstribune. [Read more](https://www.hastingstribune.com/ap/business/bpl-003-phase-3-program-initiation-on-track-for-q2-2026-following-successful-fda-end/article_c13544ca-eee6-5d94-a3eb-7b32b01acd28.html)*

---

*Source: [https://www.hastingstribune.com/ap/business/bpl-003-phase-3-program-initiation-on-track-for-q2-2026-following-successful-fda-end/article_c13544ca-eee6-5d94-a3eb-7b32b01acd28.html](https://www.hastingstribune.com/ap/business/bpl-003-phase-3-program-initiation-on-track-for-q2-2026-following-successful-fda-end/article_c13544ca-eee6-5d94-a3eb-7b32b01acd28.html)*